# Vezeeta

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vezeeta

- Industry: Healthcare IT
- Headquarters: Cairo, Egypt
- Website: www.vezeeta.com
- Total disclosed funding: $59M
- Latest round: Series E (Oct 11, 2022)
- Investors on record: 9

## About

Vezeeta LLC, headquartered in Cairo, Egypt, is a healthcare technology company specializing in an online platform for booking medical consultations and medication orders, streamlining access to healthcare services for patients across the MENA region.Founded in 2012 in Cairo, Egypt, Vezeeta LLC provides an online platform for medical appointment bookings and telemedicine services. Amir Barsoum, the founder and CEO, has driven the company's growth through various funding rounds, including the most recent Series D round in October 2022, raising USD 40.00 mn from Gulf Capital and others, bringing the total amount raised to USD 40.00 mn.Vezeeta offers a comprehensive platform for booking medical consultations and ordering medications. Its services include a user-friendly online interface for patients to find, compare, and book appointments with healthcare professionals across various specialties. Additionally, it supports telemedicine consultations, allowing patients to connect with doctors through phone or video calls. The company caters to a diverse clientele, including individuals seeking medical care, healthcare providers, and pharmaceutical companies in the Middle Eastern and North African markets, specifically Egypt, Saudi Arabia, and the United Arab Emirates.Vezeeta operates on a transaction-based revenue model, where patients pay directly for consultations via the platform. This structure includes both B2C offerings and partnerships with healthcare providers, sharing fees for appointments. The company may also offer subscription packages for healthcare providers, enhancing their visibility and access to patient management analytics.Following the USD 40.00 mn Series D funding round in October 2022, led by Gulf Capital, Vezeeta plans to accelerate its organic growth and expand through acquisitions across the Middle East and Africa. The funding will support these expansion efforts, seeking to enhance its market presence and develop new products, although specific new product launches have yet to be detailed.

## Funding rounds

- Series E, Oct 11, 2022 — VNV Global, Gulf Capital
- Series D, Feb 11, 2020, $40M — VNV Global, Gulf Capital, Crescent Enterprises, Endeavor Catalyst, Silicon Badia, BECO Capital, STV
- Series C, Sep 18, 2018, $12M — VNV Global, Crescent Enterprises, Silicon Badia, BECO Capital, STV
- Series B, Sep 1, 2016, $5M — Technology Development Fund Egypt, Silicon Badia, BECO Capital, Vostok Ventures
- Series A, Nov 1, 2014, $2.4M — Silicon Badia

## Investors

- Silicon Badia (https://capitalatlas.ai/funds/silicon-badia) — Series A, Series B, Series C, Series D
- Technology Development Fund Egypt — Series B
- BECO Capital (https://capitalatlas.ai/funds/beco-capital) — Series B, Series C, Series D
- Vostok Ventures (https://capitalatlas.ai/funds/vostok-ventures) — Series B
- VNV Global (https://capitalatlas.ai/funds/vnv-global) — Series C, Series D, Series E
- Crescent Enterprises — Series C, Series D
- STV (https://capitalatlas.ai/funds/stv) — Series C, Series D
- Gulf Capital (https://capitalatlas.ai/funds/gulf-capital) — Series D, Series E
- Endeavor Catalyst (https://capitalatlas.ai/funds/endeavor-catalyst) — Series D